Vermillion & White Wealth Management Group’s Cardiff Oncology CRDF Stock Holding History

Vermillion & White Wealth Management Group’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-500	Closed	-$1.03K	–	590
2025 Q3	$1.03K	Hold	500	–	–	﹤0.01%	530
2025 Q2	$1.57K	Hold	500	–	–	﹤0.01%	475
2025 Q1	$1.57K	Hold	500	–	–	﹤0.01%	463
2024 Q4	$2.17K	Hold	500	–	–	﹤0.01%	319
2024 Q3	$1.33K	Hold	500	–	–	﹤0.01%	304
2024 Q2	$1.11K	Hold	500	–	–	﹤0.01%	326
2024 Q1	$2.67K	Hold	500	–	–	﹤0.01%	279
2023 Q4	$740	Buy	+500	New	+$605	﹤0.01%	276

Other funds holding CRDF

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Vermillion & White Wealth Management Group's CRDF Position: Q4 2025 in Review

Vermillion & White Wealth Management Group sold out of Cardiff Oncology (CRDF) in Q4 2025, closing a stake of 500 shares — an estimated $1.03K sold.

Vermillion & White Wealth Management Group first reported a position in CRDF in Q4 2023 and held it in 8 quarters. The position peaked at $2.67K in Q1 2024. 110 funds tracked by Wall St. Rank hold CRDF as of Q4 2025.

Vermillion & White Wealth Management Group reported no remaining Cardiff Oncology position as of Q4 2025 after selling out during the quarter.
Vermillion & White Wealth Management Group sold 500 Cardiff Oncology shares in Q4 2025, an estimated $1.03K.
Vermillion & White Wealth Management Group first reported a position in Cardiff Oncology in Q4 2023 and held it in 8 quarters.
Vermillion & White Wealth Management Group's Cardiff Oncology position peaked at $2.67K in Q1 2024.
110 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2025.

Based on Vermillion & White Wealth Management Group's 13F filing for Q4 2025, filed 18 Feb 2026.